Becton Dickinson & Co. recalls
Becton Dickinson & Co. is named on 24 recalls in Recall Relay's records since November 2023, from FDA (87 recalled products: FDA lists each product as its own recall); the most recent was August 13, 2026.
All 87 recalled products, newest first.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Phoenix Panel NMIC-306. Catalog Number: 449292.Potential for quality control failures with Klebsiella pneumoniae ATCC BAA-1705 when using the CPO Ambler classification feature.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Phoenix Panel NMIC-312. Catalog Number: 449082.Potential for quality control failures with Klebsiella pneumoniae ATCC BAA-1705 when using the CPO Ambler classification feature.
-
Class IIofficial
Becton, Dickinson and Company recalls ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximDue to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Whitacre Needle 24 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Quincke Needle 22 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Quincke Needle 25 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class Iofficial
Becton Dickinson & Company recalls BD¿Spinal Tray with BD¿Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%)This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
-
Class IIofficial
Becton, Dickinson and Company recalls Swan-Ganz CatheterCatheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.
-
Class IIofficial
Becton, Dickinson and Company recalls Swan-Ganz Pacing CatheterCatheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.
-
Class IIofficial
Becton, Dickinson and Company recalls Swan-Ganz Jr CatheterCatheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.
-
Class IIofficial
Becton Dickinson & Co. recalls BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic useBD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.
-
Class IIofficial
Becton Dickinson & Co. recalls BD GasPak EZ CO2 Pouch System. Catalog Number: 260684. for microbiologic useBD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.
-
Class IIofficial
Becton Dickinson & Company recalls 10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk non-sterile units per case.During the bulk packaging process, some Luer Slip syringes were incorrectly included in a batch designated for Luer Lok syringes.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;The 2D barcodes on these cuvettes contain formatting errors that prevent the analyzing system from correctly reading the expiration date. As a result, the instrument enters an error state and the cuvettes cannot be used.
-
Class IIofficial
Becton Dickinson & Company recalls BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341;BD has confirmed through internal testing that certain device trays failed routine biocompatibility testing.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Phoenix M50 InstrumentProduct service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD MAX SystemProduct service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BACTEC Blood Culture SystemProduct service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Veritor Connect SoftwareProduct service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BACTEC Blood Culture SystemProduct service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD EpiCenter Microbiology Data Management SystemProduct service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD COR System Software. Model Number: 444829.Potential for functionality issue that supports the Over labeling feature and could lead to possible false negative results.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BACTEC MGIT 960 PZA Kit. IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosisBD has received additional complaints of intermittent false resistance results for PZA during susceptibility testing of Mycobacterium tuberculosis isolates.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL TB Stain Kit KOne component of the kit was shipped with an expiration date of 30Sep2024 while the Certificate of Analysis (COA) indicated an expiration date of 30Apr2025.
-
Class IIofficial
Becton Dickinson & Co. recalls BD PCR Cartridges used with MAX System. Model Number: 437519Potential for signal drift in specific lots of BD PCR Cartridges.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) - In-Vitro BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) are used for semiBD identified through potency testing as part of a stability test request to monitor Ampicillin AM-2 due to decrease in potency results of 65% at 18 months, may result in falsely resistant result for ampicillin susceptibility
-
Class IIofficial
Becton Dickinson & Co. recalls BD Phoenix M50 Automated Microbiology System Version or Model: 443624 Catalog Number: 443624BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BACTEC 9120 System Version or Model: 445570 Catalog Number: 445570BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BACTEC FX40 Instrument Version or Model: 442296 Catalog Number: 442296BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD COR PX Instrument Version or Model: 443988 Catalog Number: 443988BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD EpiCenter Data Management System Version or Model: 440887 Catalog Number: 440887BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD COR MX Instrument Version or Model: 443989 Catalog Number: 443989BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BACTEC 9240 System Version or Model: 445475 Catalog Number: 445475BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD EpiCenter Data Management SystemBD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD EpiCenter Single User Software Version or Model: 441007 Catalog Number: 441007BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BACTEC FXBD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD MAX SystemBD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Synapsys Informatics Solution (Laboratory Solution) Version or Model: 444150 Catalog Number: 444150BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD COR GX Instrument Version or Model: 443990 Catalog Number: 443990BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Synapsys Informatics Solution with software versions: 4.20Synapsys software versions 4.20, 4.30, 5.10, 5.20, or 5.30 and utilizing the in-line breakpoint feature, an error is occurring where BD Synapsys will incorrectly display breakpoints for organisms that do not have defined breakpoints in CLSI or EUCAST. This occurs when the identified organism is included in the same interpretive group as a species for which there is a specific breakpoint. May result in either a false susceptible or false resistant result. A false susceptible result can cause inadequate or incomplete antibiotic treatment due to the use of an ineffective antibiotic, and a false resistant result may limit access to a preferred antibiotic regimen with possible elongation of therapy
-
Class IIofficial
Becton Dickinson & Co. recalls BD Phoenix 100-Intended for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clEscherichia coli (E. coli) misidentification for clinical samples that were tested on BD Phoenix" M50 instrument and BD Phoenix" 100, may lead to misdiagnosis and inappropriate treatment of infections caused by E. coli,
-
Class IIofficial
Becton Dickinson & Co. recalls BD Phoenix M50 instrument -Intended for the rapid identification (ID) and antimicrobial susceptibility testingEscherichia coli (E. coli) misidentification for clinical samples that were tested on BD Phoenix" M50 instrument and BD Phoenix" 100, may lead to misdiagnosis and inappropriate treatment of infections caused by E. coli,
-
Class IIofficial
Becton Dickinson & Co. recalls BD BACTEC MGIT 960 PZA Kit)- IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosiMay intermittently produce falsely resistant results for pyrazinamide (PZA) during susceptibility testing of Mycobacterium tuberculosis isolates.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Kiestra Urine Culture Application Powered by BD Synapsys Informatics Solution; Catalog (Ref): 444900;There is a potential risk that the image colony count does not adequately reflect the actual plate colony count and may lead to inaccurate counts that would impact patient diagnosis and subsequent care.
-
Class IIofficial
Becton Dickinson & Co. recalls BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasalAssays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.
-
Class IIofficial
Becton Dickinson & Co. recalls BD Phoenix NMIC-306 Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) poProducts were found to have confirmed drug cross contamination prior to release may lead to incorrect, inadequate, or absent antibiotic treatment or delay in results
-
Class IIofficial
Becton Dickinson & Co. recalls BD Phoenix Yeast ID Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) poEsculin, a substrate used in other panels and normally in A16 well, was found in A17 well. A17 in yeast panels is supposed to be an empty well and is not a part of the normal ID evaluation. However, A17 is checked for fluorescence and if anything is found, the system will abort the panel with the message Fluorescent interference has been detected. Esculin is expected to trigger this fluorescence and test cancellation.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Clarithromycin- 15 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 ¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Doripenem- 15 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftriaxone- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefuroxime- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ampicillin - 10 ¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefixime - 5 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftazidime- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Augmentin - 3¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Levofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Aztreonam - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ciprofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ertapenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Chloramphenicol- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Moxifloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Imipenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefepime - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftaroline - 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Meropenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Tetracycline 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefotaxime - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefaclor - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Minocycline - 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls Sensi Disc Amoxicillin with Clavulanic Acid 20/10 ¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefpodoxime - 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Rifampin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Azithromycin -15 ¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Company recalls PosiFlush Prefilled Saline Syringe with General Pump Compatibility (10mL Syringe with 10mL Saline Fill)An incorrect stopper was used in nine lots of 10mL BD PosiFlush Normal Saline Flush Syringes with General Pump Compatibility. The use of BD PosiFlush Prefilled Flush Syringes with this stopper causes an increase in injection force, which has the potential to trigger alarms if used with a syringe pump.
-
Class IIofficial
Becton Dickinson & Company recalls BD Alaris Pump infusion sets (Product NameAffected infusion sets labeled as free of DEHP actually do contain di(2-ethylhexyl) phthalate (DEHP).
-
Class IIofficial
Becton Dickinson & Company recalls BD Extension Sets (Product NameAffected infusion sets labeled as free of DEHP actually do contain di(2-ethylhexyl) phthalate (DEHP).
-
Class IIofficial
Becton Dickinson & Company recalls BD gravity sets (Product NameAffected infusion sets labeled as free of DEHP actually do contain di(2-ethylhexyl) phthalate (DEHP).
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Becton Dickinson & Co. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts